Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

New Hampshire

Phase 1 cancer trials in New Hampshire

14 Phase 1 cancer studies are recruiting participants at sites in 1 city across New Hampshire as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every New Hampshire city with a recruiting study

By research area: Breast Cancer (7), Lung Cancer (4), Prostate Cancer (2), Lymphoma (1).

Lebanon (14).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in New Hampshire

Basic details from each study's public record (the 12 most recently updated of 14). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Recruiting in
    Lebanon
    Registry record
    NCT06253871 · updated
  2. aPBI Re-irradiation

    • Phase 1/2
    • Ages 40 and older
    • All sexes
    Sponsor
    Dartmouth-Hitchcock Medical Center
    Recruiting in
    Lebanon
    Registry record
    NCT07612254 · updated
  3. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Lebanon
    Registry record
    NCT07488676 · updated
  4. A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Lebanon
    Registry record
    NCT06997029 · updated
  5. A Study of Tetrathiomolybdate (TM) Plus Capecitabine

    • Phase 1/2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Dartmouth-Hitchcock Medical Center
    Recruiting in
    Lebanon
    Registry record
    NCT06134375 · updated
  6. Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    OncoTherapy Science, Inc.
    Recruiting in
    Lebanon
    Registry record
    NCT02926690 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in New Hampshire on ClinicalTrials.gov.

Lung cancer: recently updated in New Hampshire

  1. KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Lebanon
    Registry record
    NCT04165070 · updated
  2. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Daiichi Sankyo
    Recruiting in
    Lebanon
    Registry record
    NCT06362252 · updated
  3. A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    7 Hills Pharma, LLC
    Recruiting in
    Lebanon
    Registry record
    NCT06362369 · updated
  4. A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Conjupro Biotherapeutics, Inc.
    Recruiting in
    Lebanon
    Registry record
    NCT05948865 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in New Hampshire on ClinicalTrials.gov.

Prostate cancer: recently updated in New Hampshire

  1. Telmisartan in Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Tyler J Curiel
    Recruiting in
    Lebanon
    Registry record
    NCT06168487 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in New Hampshire on ClinicalTrials.gov.

Ask about studies in New Hampshire

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call